Literature DB >> 12761180

Regulation of a mitogen-activated protein kinase kinase kinase, MLTK by PKN.

Mikiko Takahashi1, Yusuke Gotoh, Takayuki Isagawa, Tamako Nishimura, Emiko Goyama, Hon-Song Kim, Hideyuki Mukai, Yoshitaka Ono.   

Abstract

PKNalpha is a fatty acid- and Rho-activated serine/threonine protein kinase having a catalytic domain homologous to members of the protein kinase C family. Recently it was reported that PKNalpha is involved in the p38 mitogen-activated protein kinase (MAPK) signaling pathway. To date, however, how PKNalpha regulates the p38gamma MAPK signaling pathway is unclear. Here we demonstrate that PKNalpha efficiently phosphorylates MLTKalpha (MLK-like mitogen-activated protein triple kinase), which was recently identified as a MAPK kinase kinase (MAPKKK) for the p38 MAPK cascade. Phosphorylation of MLTKalpha by PKNalpha enhances its kinase activity in vitro. Expression of the kinase-negative mutant of PKNalpha inhibited the mobility shift of MLTKalpha caused by osmotic shock in SDS-PAGE. Furthermore, PKNalpha associates with each member of the p38gamma MAPK signaling pathway (p38gamma, MKK6, and MLTKalpha). These results suggest that PKNalpha functions as not only an upstream activator of MLTKalpha but also a putative scaffold protein for the p38gamma MAPK signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761180     DOI: 10.1093/jb/mvg022

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Hypotonic swelling-induced activation of PKN1 mediates cell survival in cardiac myocytes.

Authors:  Katsuya Kajimoto; Dan Shao; Hiromitsu Takagi; Gregorio Maceri; Daniela Zablocki; Hideyuki Mukai; Yoshitaka Ono; Junichi Sadoshima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

2.  A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in α1-adrenergic receptor-induced p38 activation.

Authors:  Luca Cariolato; Sabrina Cavin; Dario Diviani
Journal:  J Biol Chem       Date:  2011-01-11       Impact factor: 5.157

3.  Structure of the Human Protein Kinase ZAK in Complex with Vemurafenib.

Authors:  Sebastian Mathea; Kamal R Abdul Azeez; Eidarus Salah; Cynthia Tallant; Finn Wolfreys; Rebecca Konietzny; Roman Fischer; Hua Jane Lou; Paul E Brennan; Gisela Schnapp; Alexander Pautsch; Benedikt M Kessler; Benjamin E Turk; Stefan Knapp
Journal:  ACS Chem Biol       Date:  2016-03-31       Impact factor: 5.100

4.  Development of an intracellularly acting inhibitory peptide selective for PKN.

Authors:  Kazuhiro Shiga; Kentaro Takayama; Shiroh Futaki; Jessica E Hutti; Lewis C Cantley; Katsuko Ueki; Yoshitaka Ono; Hideyuki Mukai
Journal:  Biochem J       Date:  2009-12-23       Impact factor: 3.857

5.  The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer.

Authors:  C Rey; B Faustin; I Mahouche; R Ruggieri; C Brulard; F Ichas; I Soubeyran; L Lartigue; F De Giorgi
Journal:  Oncogene       Date:  2015-11-02       Impact factor: 9.867

6.  A rho-binding protein kinase C-like activity is required for the function of protein kinase N in Drosophila development.

Authors:  Martha Betson; Jeffrey Settleman
Journal:  Genetics       Date:  2007-05-16       Impact factor: 4.562

7.  Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration.

Authors:  Sylvie Lachmann; Amy Jevons; Manu De Rycker; Adele Casamassima; Simone Radtke; Alejandra Collazos; Peter J Parker
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

8.  Impaired lymphocyte trafficking in mice deficient in the kinase activity of PKN1.

Authors:  Rana Mashud; Akira Nomachi; Akihide Hayakawa; Koji Kubouchi; Sally Danno; Takako Hirata; Kazuhiko Matsuo; Takashi Nakayama; Ryosuke Satoh; Reiko Sugiura; Manabu Abe; Kenji Sakimura; Shigeharu Wakana; Hiroyuki Ohsaki; Shingo Kamoshida; Hideyuki Mukai
Journal:  Sci Rep       Date:  2017-08-09       Impact factor: 4.379

9.  PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells.

Authors:  Cordula A Jilg; Anett Ketscher; Eric Metzger; Barbara Hummel; Dominica Willmann; Vanessa Rüsseler; Vanessa Drendel; Axel Imhof; Manfred Jung; Henriette Franz; Stefanie Hölz; Malte Krönig; Judith M Müller; Roland Schüle
Journal:  Oncotarget       Date:  2014-12-30

10.  PKN1 kinase-negative knock-in mice develop splenomegaly and leukopenia at advanced age without obvious autoimmune-like phenotypes.

Authors:  Salman Mahmud Siddique; Koji Kubouchi; Yuka Shinmichi; Nana Sawada; Reiko Sugiura; Yasushi Itoh; Shunsuke Uehara; Kanae Nishimura; Shunsuke Okamura; Hiroyuki Ohsaki; Shingo Kamoshida; Yusuke Yamashita; Shinobu Tamura; Takashi Sonoki; Hiroshi Matsuoka; Tomoo Itoh; Hideyuki Mukai
Journal:  Sci Rep       Date:  2019-09-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.